228. 閉塞性細気管支炎 Bronchiolitis obliterans Clinical trials / Disease details

臨床試験数 : 96 / 薬物数 : 125 - (DrugBank : 34) / 標的遺伝子数 : 33 - 標的パスウェイ数 : 155

2 trials found

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT03603899 (ClinicalTrials.gov)	August 2020	4/10/2017	Hp129 Xenon Imaging and BOS in Lung Transplantation	Imaging and Understanding Bronchiolitis Obliterans Syndrome (BOS) in Lung Transplantation With Hyperpolarized 129Xenon MR Lung Imaging	Bronchiolitis Obliterans	Drug: Hp 129Xenon	Children's Hospital Medical Center, Cincinnati	NULL	Recruiting	6 Years	N/A	All	45	Phase 1/Phase 2	United States
2	NCT04029636 (ClinicalTrials.gov)	August 2019	7/6/2019	Hyperpolarized 129Xe MRI for the Assessment of BOS With Late Onset LONIPC	Hyperpolarized 129Xe Magnetic Resonance Imaging for the Early Detection of Bronchiolitis Obliterans Syndrome (BOS) and Other Late Onset Non-infectious Pulmonary Complications (LONIPCs) Following Hematopoietic Stem Cell Transplantation	Bronchiolitis Obliterans	Other: Inhaled Hyperpolarized Xenon-129	Hamilton Health Sciences Corporation	NULL	Not yet recruiting	18 Years	70 Years	All	45		Canada